4//SEC Filing
Stecyk Chrystyna Bedrij 4
Accession 0001062993-23-011116
CIK 0001205922other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:33 PM ET
Size
9.4 KB
Accession
0001062993-23-011116
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Stecyk Chrystyna Bedrij
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-11+143,848→ 143,848 totalExercise: $0.41From: 2024-05-11→ Common Stock (143,848 underlying)
Holdings
- 28,586
Stock Option (Right to Buy)
Exercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying) - 25,087
Stock Option (Right to Buy)
Exercise: $3.95From: 2021-05-14→ Common Stock (25,087 underlying) - 53,254
Stock Option (Right to Buy)
Exercise: $1.12From: 2023-05-12→ Common Stock (53,254 underlying)
Footnotes (4)
- [F1]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F2]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
- [F3]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
- [F4]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001811625
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:33 PM ET
- Size
- 9.4 KB